The media had reports that Mylan may come out with a delisting offer for Matrix and are looking at buying the residual stake.
The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company.
Matrix Laboratories Limited has vide its letter inter-alia stated,"As on date Mylan Laboratories Inc.,USA is neither contemplating to buy residual stake nor delist the securities of the Company from the Stock Exchanges. Hence, the news item is incorrect and baseless." -- www.nseindia.com
Comment and add to the story without registration, but keep the comments meaningful please. Links are not accepted.
